Journals / Journal of Health Sciences and Medicine / 2026 / Volume: 9 Issue: 4

Subclinical thyroid dysfunction and clinical severity in perimenopausal abnormal uterine bleeding: a retrospective cohort study

Mehmet Çopuroğlu(Kayseri Şehir Hastanesi)0009-0008-2375-6253
Dilek Bayraktar(EGE ÜNİVERSİTESİ, EGE TIP FAKÜLTESİ)0000-0002-3200-7456
Derya Koçer(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, KAYSERİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ)0000-0002-6780-6776
Pages
—
Publication Date
2026-07-20
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, given the retrospective observational design, these findings do not establish causality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: To examine the association between thyroid dysfunction and bleeding severity, anemia burden, and management outcomes in perimenopausal women with abnormal uterine bleeding (AUB).
📊
Key Findings & Data:Methods: In this retrospective cohort study, 742 perimenopausal women aged 40-55 years with AUB were evaluated between January 2014 and December 2024.
💡
Conclusion & Impact:However, given the retrospective observational design, these findings do not establish causality.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Abnormal uterine bleeding · perimenopause · thyroid dysfunction

Abstract

Aims: To examine the association between thyroid dysfunction and bleeding severity, anemia burden, and management outcomes in perimenopausal women with abnormal uterine bleeding (AUB). Methods: In this retrospective cohort study, 742 perimenopausal women aged 40-55 years with AUB were evaluated between January 2014 and December 2024. Thyroid status was categorized as euthyroid, subclinical hypothyroidism, overt hypothyroidism, subclinical hyperthyroidism, or overt hyperthyroidism based on serum thyroid-stimulating hormone and free thyroxine levels. Severe AUB, anemia, and management outcomes (iron therapy, blood transfusion, and procedural interventions) were analyzed using multivariable logistic regression adjusted for demographic and metabolic covariates. Receiver operating characteristic analyses were used to explore the standalone discriminatory performance of thyroid-stimulating hormone for severe AUB and moderate-to-severe anemia. Results: Thyroid dysfunction was identified in 29.4% of participants. Severe AUB and moderate-to-severe anemia were more frequent among women with subclinical and overt hypothyroidism. Thyroid dysfunction was independently associated with severe AUB (aOR 2.21; 95% CI 1.54-3.18), anemia (aOR 1.89; 95% CI 1.33-2.68), and escalation of care (aOR 1.97; 95% CI 1.28-3.02), as well as increased likelihood of iron therapy and blood transfusion. A thyroid-stimulating hormone threshold near 4.0 mIU/L showed moderate discrimination for severe AUB and anemia and should be interpreted as an exploratory risk-enrichment value rather than a definitive diagnostic or treatment cut-off. Conclusion: Thyroid dysfunction, particularly subclinical hypothyroidism, was independently associated with increased bleeding severity, anemia burden, and greater healthcare utilization in perimenopausal AUB. However, given the retrospective observational design, these findings do not establish causality.

🔖

Cite This Article

Çopuroğlu, M., Çopuroğlu, Ö. B., Bayraktar, D., Koçer, D. (2026). Subclinical thyroid dysfunction and clinical severity in perimenopausal abnormal uterine bleeding: a retrospective cohort study. Journal of Health Sciences and Medicine, Volume: 9 Issue: 4. https://doi.org/10.32322/jhsm.1938261

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (28)

  1. Dreisler E, Frandsen CS, Ulrich L. Perimenopausal abnormal uterine bleeding. Maturitas. 2024;184:107944. doi:10.1016/j.maturitas.2024.107944
  2. Jain V, Munro MG, Critchley HOD. Contemporary evaluation of women and girls with abnormal uterine bleeding: FIGO systems 1 and 2. Int J Gynaecol Obstet. 2023;162(suppl 1):29-42. doi:10.1002/ijgo.14946
  3. MacGregor B, Munro MG, Lumsden MA. Therapeutic options for the management of abnormal uterine bleeding. Int J Gynaecol Obstet. 2023;162(suppl 1):43-57. doi:10.1002/ijgo.14947
  4. Zhang CY, Li H, Zhang S, et al. Abnormal uterine bleeding patterns determined through menstrual tracking among participants in the Apple Women’s Health Study. Am J Obstet Gynecol. 2023;228(2):213.e1-213.e16. doi:10.1016/j.ajog.2022.10.029
  5. Thakur M, Maharjan M, Tuladhar H, et al. Thyroid dysfunction in patients with abnormal uterine bleeding in a tertiary care hospital: a descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2020;58(225):333-337. doi:10.31729/jnma.5033
  6. Joshi BR, Rizal S, Subedi S. Thyroid dysfunction in patients with abnormal uterine bleeding in a tertiary hospital of Eastern Nepal: a descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2021;59(239):635-639. doi:10.31729/jnma.6487
  7. Sahu HD, Varma AV, Karmarkar S, et al. Endometrial histopathology in abnormal uterine bleeding and its relation with thyroid profile and endometrial thickness. Cureus. 2023;15(4):e37931. doi:10.7759/cureus.37931
  8. Urgatz B, Razvi S. Subclinical hypothyroidism, outcomes and management guidelines: a narrative review and update of recent literature. Curr Med Res Opin. 2023;39(3):351-365. doi:10.1080/03007995.2023.2165811
  9. Xu Q, Wang Y, Shen X, et al. The effect of subclinical hypothyroidism on coagulation and fibrinolysis: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022;13:861746. doi:10.3389/fendo.2022.861746
  10. Hoffmann MA, Knoll SN, Baqué PE, et al. The influence of hypothyroid metabolic status on blood coagulation and the acquired von Willebrand syndrome. J Clin Med. 2023;12(18):5905. doi:10.3390/jcm12185905
  11. Wang Y, Ding C, Guo C, et al. Association between thyroid dysfunction and venous thromboembolism: a systematic review and meta-analysis. Medicine (Baltimore). 2023;102(11):e33301. doi:10.1097/MD.0000000000033301
  12. Sabre A, Serventi L, Nuritdinova D, et al. Abnormal uterine bleeding types according to the PALM-COEIN FIGO classification in a medically underserved American community. J Turk Ger Gynecol Assoc. 2021;22(2):91-97. doi:10.4274/jtgga.galenos.2021.2020.0228
  13. Sebtain A, Qasim M, Bahadur A, et al. Subclinical hypothyroidism in perimenopausal abnormal uterine bleeding patients. Cureus. 2022;14(2):e21839. doi:10.7759/cureus.21839
  14. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387-395. doi:10.1097/gme.0b013e31824d8f40
  15. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028. doi:10.1089/thy.2012.0205
  16. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421. doi:10.1089/thy.2016.0229
  17. World Health Organization. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. World Health Organization; 2011.
  18. Lee JH, Cheng EO, Choi KM, et al. 2020 Hong Kong College of Obstetricians and Gynaecologists guideline on investigations of premenopausal women with abnormal uterine bleeding. Hong Kong Med J. 2020. doi:10.12809/hkmj208897
  19. Mintsopoulos V, Tannenbaum E, Malinowski AK, et al. Identification and treatment of iron-deficiency anemia in pregnancy and postpartum: a systematic review. Int J Gynaecol Obstet. 2024;164(2):460-475. doi:10.1002/ijgo.14978
  20. Atia YA, Mohammed ST, Abdullah SS, et al. Effects of subclinical hypothyroidism in type II diabetes mellitus patients on biochemical, coagulation, and fibrinolysis status. J Adv Pharm Technol Res. 2024;15(2):130-134. doi:10.4103/JAPTR.JAPTR_89_24
  21. Terrarosa AK, DeMaria LN, North VS, et al. Menstrual irregularities and amenorrhea in thyroid eye disease patients treated with teprotumumab. Ophthalmic Plast Reconstr Surg. 2024;40(3):312-315. doi:10.1097/IOP.0000000000002569
  22. Thasneem K, Kalarani IB, Jayaprasad P, et al. Genes linked with early menopause and the pathogenesis of its associated diseases: a systematic review. Middle East Fertil Soc J. 2022;27(1):2. doi:10.1186/s43043-021-00093-0
  23. Munro MG, Critchley HOD, Fraser IS, et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years. Int J Gynaecol Obstet. 2018;143(3):393-408. doi:10.1002/ijgo.12666
  24. Tian Y, Bai B, Wang L, et al. Contributing factors related to abnormal uterine bleeding in perimenopausal women: a case-control study. J Health Popul Nutr. 2024;43(1):52. doi:10.1186/s41043-024-00540-4
  25. Ren B, Zhu Y. A new perspective on thyroid hormones: crosstalk with reproductive hormones in females. Int J Mol Sci. 2022;23(5):2708. doi:10.3390/ijms23052708
  26. Garofalo V, Condorelli RA, Cannarella R, et al. Relationship between iron deficiency and thyroid function: a systematic review and meta-analysis. Nutrients. 2023;15(22):4790. doi:10.3390/nu15224790
  27. Adan AAA, Khan AA, Abid MA, et al. Thyroid dysfunction and its relationship with abnormal uterine bleeding in females. Indus J Biosci Res. 2025;3(3):341-345. doi:10.70749/ijbr.v3i3.836
  28. Ivanović R, Joksimović B, Čančar V, et al. Factors associated with abnormal uterine bleeding in perimenopausal women. Clin Exp Obstet Gynecol. 2024;51(2):37. doi:10.31083/j.ceog5102037